Stephen Gottschalk, MD, is chair of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children’s Research Hospital in Memphis, Tennessee.

Dr. Gottschalk also serves as a Co-Director of the Center of Excellence for Pediatric Immuno-Oncology and as an Endowed Chair in Bone Marrow Transplantation & Cellular Therapy. 

Dr. Gottschalk actively conducts investigator-initiated early-phase clinical studies and, in the laboratory, oversees a team of MD and PhD researchers on peer-reviewed projects aimed at overcoming current limitations of adoptive cell therapies for cancer. He co-leads the translational immuno-oncology and immunotherapy initiative at St. Jude and is committed to training the next generation of scientists and academic physicians.

Dr. Gottschalk earned his MD at Georg-August University in his native Germany before moving to the United States and completing a pediatric residency at Baylor University. He became an ACGT Research Fellow in 2019 for a study on cell therapy in sarcoma and is engaged in an ACGT-funded cross-institution collaboration on synthetic T-cell therapy for recurrent pediatric brain tumors, specifically medulloblastoma and ependymoma.